-
Start Preamble
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain Research Coordinating Committee (IPRCC) meeting.
The meeting will feature invited speakers and discussions of committee business items including strategic planning for Federal pain research and the National Pain Strategy.
The meeting will be open to the public and accessible by live webcast and conference call.
Name of Committee: Interagency Pain Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: September 24, 2014.
Time: 8:30 a.m. to 5:00 p.m. *Eastern Time*—Approximate end time.
Agenda: The meeting will feature invited speakers and discussions of Committee business items including the National Pain Strategy and long term strategic planning for Federal pain research.
Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
Call in Teleconference Line (Listen Only): Dial: 888-945-5891, Participant Passcode: 1242293.
Cost: The meeting is free and open to the public.
Webcast Live: http://videocast.nih.gov/.
Deadlines: Notification of intent to present oral comments: Friday, September 12, 2014, by 5:00 p.m. ET.
Submission of written/electronic statement for oral comments: Wednesday, September 17, 2014, by 5:00 p.m. ET.
Submission of written comments: Friday, September 19, 2014, by 5:00 p.m. ET.
Access: Medical Center Metro (Red Line), Visitor Information: http://www.nih.gov/about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D., Pain Policy Advisor, Office of Pain Policy, Officer of the Director, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, Phone: (301) 451-4460, Email: Linda.Porter@nih.gov.
Please Note:
Any member of the public interested in presenting oral comments to the Committee must notify the Contact Person listed on this notice by 5:00 p.m. ET on Friday, September 12, 2014, with their request to present oral comments at the meeting. Interested individuals and representatives of organizations must submit a written/electronic copy of the oral statement/comments including a brief description of the organization represented by 5:00 p.m. ET on Wednesday, September 17, 2014.
Statements submitted will become a part of the public record. Only one representative of an organization will be allowed to present oral comments on behalf of that organization, and presentations will be limited to three to five minutes per speaker, depending on number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received, along with the required submission of the written/electronic statement by the specified deadline. If special accommodations are needed, please email the Contact Person listed above.
In addition, any interested person may submit written comments to the IPRCC prior to the meeting by sending the comments to the Contact Person listed on this notice by 5:00 p.m. ET, Friday, September 19, 2014. The comments should include the name and, when applicable, the business or professional affiliation of the interested person. All written comments received by the deadlines for both oral and written public comments will be provided to the IPRCC for their consideration and will become part of the public record.
The meeting will be open to the public through a conference call phone number and webcast live on the Internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the conference call or webcast, please call Operator Service on (301) 496-4517 for conference call issues and the NIH IT Service Desk at (301) 496-4357, toll free (866) 319-4357, for webcast issues.
Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least seven days prior to the meeting.
As a part of security procedures, attendees should be prepared to present a photo ID during the security process to get on the NIH campus. For a full description, please see: http://www.nih.gov/about/visitorsecurity.htm.
Information about the IPRCC is available on the Web site: http://iprcc.nih.gov/.
Start SignatureDated: August 4, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-18849 Filed 8-8-14; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 9/24/2014
- Published:
- 08/11/2014
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2014-18849
- Dates:
- September 24, 2014.
- Pages:
- 46847-46847 (1 pages)
- PDF File:
- 2014-18849.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute